IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis
about
Mesenchymal stem cells markedly suppress inflammatory bone destruction in rats with adjuvant-induced arthritis.Disease-dependent local IL-10 production ameliorates collagen induced arthritis in micePatient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology.Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.Prospect and progress of gene therapy in treating atherosclerosis.Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines.GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin's B lymphomas via NF-κB-dependent induction of HIF-1α.Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs.Suppression of the inflammatory response by disease-inducible interleukin-10 gene therapy in a three-dimensional micromass model of the human synovial membraneGenome Engineering for Personalized Arthritis Therapeutics.Intra-articular drug delivery systems for joint diseases.The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia modelClonal dynamics in osteosarcoma defined by RGB marking
P2860
Q34396114-3D91910C-FF44-42B5-A657-7A005D4FE8C9Q34482730-FA11CAAA-FFB2-48E8-9658-DD15CED7B250Q35695531-5F29E622-1704-4FB4-A0BE-871EEE6E439EQ36600997-B2CA3F9C-EB53-45EC-93CA-BA81EDF01300Q38578275-35AF0BC8-3D7C-4DE1-B4FA-2A0B402F822FQ38829316-E245074F-2BBA-4285-9179-10D58A8C517BQ38940618-4DAF69C8-8D24-4E88-8ACF-57BBEFB580FFQ39018487-CF7FAFE8-D9EB-4AE9-8EC3-B9DBF6915A4EQ42084870-CE25CDE5-C575-43AA-A9D3-435E04D6C580Q42278257-BA919280-942D-420C-A463-474AECCCE300Q42360105-0B91FAA8-8845-4E64-85C2-4AA0B10881A0Q47697061-898C346F-B1B3-49CE-BF17-2D145EFE4E27Q52721095-D89D9AE7-58F4-4CA6-80DB-183F1C1C8CE5Q58063547-24F433B4-5A3B-4463-BC65-0905FD9230EAQ59126293-26CD7C8B-E8BC-4F7D-959D-69321E7083E6
P2860
IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@ast
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@en
type
label
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@ast
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@en
prefLabel
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@ast
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@en
P2093
P2860
P50
P356
P1433
P1476
IL10 released by a new inflamm ...... ates zymosan-induced arthritis
@en
P2093
Amelia Escolano
Arántzazu Alfranca
Guillermo Garaulet
María Torrente
Raquel López-Fontal
P2860
P304
P356
10.1038/MT.2012.131
P577
2012-07-03T00:00:00Z